Alcon (2U3) Stock Forecast & Price Target

4 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

2U3 Analyst Ratings

Moderate Buy

8 Buy

2 Hold

1 Sell

Based on 11 analysts giving stock ratings to

Alcon

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

2U3 Stock 12 Month Forecast

Average Price Target

€76.98

▲(28.38% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for Alcon in the last 3 months. The average price target is €76.98 with a high forecast of €91.06 and a low forecast of €51.42. The average price target represents a 28.38% change from the last price of €59.96.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"50":"€50","71":"€71","92":"€92","60.5":"€60.5","81.5":"€81.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":91.05965,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€91.06</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":76.9773313952,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€76.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":51.42192,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€51.42</span>\n  </div></div>","useHTML":true}}],"tickPositions":[50,60.5,71,81.5,92],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,59.52,61.946126923076925,64.37225384615385,66.79838076923077,69.2245076923077,71.65063461538462,74.07676153846154,76.50288846153848,78.92901538461538,81.35514230769232,83.78126923076924,86.20739615384616,88.63352307692308,{"y":91.05965,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,59.52,60.862871645784615,62.205743291569235,63.54861493735385,64.89148658313846,66.23435822892307,67.5772298747077,68.92010152049231,70.26297316627692,71.60584481206153,72.94871645784615,74.29158810363077,75.63445974941538,{"y":76.9773313952,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,59.52,58.89707076923077,58.27414153846154,57.65121230769231,57.02828307692308,56.40535384615385,55.78242461538461,55.15949538461538,54.53656615384615,53.91363692307692,53.29070769230769,52.66777846153846,52.04484923076923,{"y":51.42192,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":75.038,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.912,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.956,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.006,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.972,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.992,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.076,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.455,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.827,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.299,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.34,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.28,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.52,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€91.06

Average Price Target€76.98

Lowest Price Target€51.42

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Falko Friedrichs

Deutsche Bank

€74.99→€78.2

Buy

30.43%

Upside

Reiterated

08/17/26

Alcon price target raised to CHF 73 from CHF 70 at Deutsche BankAlcon price target raised to CHF 73 from CHF 70 at Deutsche Bank

Graham Doyle

UBS

€92.13→€88.92

Buy

48.29%

Upside

Reiterated

08/14/26

Analysts' Top Healthcare Picks: Alcon (ALC), Kuros Biosciences (CSBTF)

Anthony Petrone

Mizuho Securities

€72.78

Buy

21.39%

Upside

Reiterated

08/13/26

Analysts Offer Insights on Healthcare Companies: Spruce Biosciences (NASDAQ: SPRB) and Alcon (NYSE: ALC)

Steven Lichtman

William Blair

―

Hold

―

Assigned

08/12/26

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT) and Alcon (NYSE: ALC)

David Adlington

J.P. Morgan

€67.13

Hold

11.96%

Upside

Reiterated

08/12/26

J.P. Morgan Sticks to Their Hold Rating for Alcon (ALC)

David Saxon

Needham

€81.35→€83.92

Buy

39.95%

Upside

Reiterated

08/11/26

Analyst Reiterates Buy on Alcon After Q2 Beat, Raised Earnings Outlook, and Strengthening Multi-Pillar Growth Drivers

Sam England

Berenberg Bank

€91.06

Buy

51.87%

Upside

Reiterated

08/07/26

Berenberg Bank Keeps Their Buy Rating on Alcon (ALC)

Julien Ouaddour

Bank of America Securities

€53.56→€51.42

Sell

-14.24%

Downside

Reiterated

07/21/26

Alcon Cut to Sell as Underperformance, Competitive Pressure and Softer Markets Drive Price Target Reduction from CHF50 to CHF48

Jasper Hellweg

Argus Research

€72.78

Buy

21.39%

Upside

Reiterated

07/01/26

Alcon price target lowered to $85 from $90 at ArgusAlcon price target lowered to $85 from $90 at Argus

Brett Fishbin

KeyBanc

€75.35

Buy

25.67%

Upside

Reiterated

06/12/26

Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (NYSE: EVMN), Immunome (NASDAQ: IMNM) and Alcon (NYSE: ALC)

Veronika Dubajova

Citi

€95.9→€88.2

Buy

47.09%

Upside

Reiterated

06/11/26

Alcon (ALC) Gets a Buy from Citi

Thomas Stephan

Stifel Nicolaus

€59.94

Hold

-0.03%

Downside

Reiterated

05/21/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alcon (NYSE: ALC) and Oruka Therapeutics (NASDAQ: ORKA)

Jeff Johnson

Robert W. Baird

€83.92→€77.07

Buy

28.53%

Upside

Reiterated

05/07/26

Alcon price target lowered to $90 from $98 at BairdAlcon price target lowered to $90 from $98 at Baird

Matt Miksic

Barclays

€66.79

Hold

11.39%

Upside

Reiterated

05/06/26

Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (NASDAQ: ACAD), Qiagen (NYSE: QGEN) and Alcon (NYSE: ALC)

Jack Reynolds-Clark

RBC Capital

€85.7

Buy

42.93%

Upside

Reiterated

05/06/26

Alcon (ALC) Gets a Buy from RBC Capital

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Falko Friedrichs

Deutsche Bank

€74.99→€78.2

Buy

30.43%

Upside

Reiterated

08/17/26

Alcon price target raised to CHF 73 from CHF 70 at Deutsche BankAlcon price target raised to CHF 73 from CHF 70 at Deutsche Bank

Graham Doyle

UBS

€92.13→€88.92

Buy

48.29%

Upside

Reiterated

08/14/26

Analysts' Top Healthcare Picks: Alcon (ALC), Kuros Biosciences (CSBTF)

Anthony Petrone

Mizuho Securities

€72.78

Buy

21.39%

Upside

Reiterated

08/13/26

Analysts Offer Insights on Healthcare Companies: Spruce Biosciences (NASDAQ: SPRB) and Alcon (NYSE: ALC)

Steven Lichtman

William Blair

―

Hold

―

Assigned

08/12/26

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT) and Alcon (NYSE: ALC)

David Adlington

J.P. Morgan

€67.13

Hold

11.96%

Upside

Reiterated

08/12/26

J.P. Morgan Sticks to Their Hold Rating for Alcon (ALC)

David Saxon

Needham

€81.35→€83.92

Buy

39.95%

Upside

Reiterated

08/11/26

Analyst Reiterates Buy on Alcon After Q2 Beat, Raised Earnings Outlook, and Strengthening Multi-Pillar Growth Drivers

Sam England

Berenberg Bank

€91.06

Buy

51.87%

Upside

Reiterated

08/07/26

Berenberg Bank Keeps Their Buy Rating on Alcon (ALC)

Julien Ouaddour

Bank of America Securities

€53.56→€51.42

Sell

-14.24%

Downside

Reiterated

07/21/26

Alcon Cut to Sell as Underperformance, Competitive Pressure and Softer Markets Drive Price Target Reduction from CHF50 to CHF48

Jasper Hellweg

Argus Research

€72.78

Buy

21.39%

Upside

Reiterated

07/01/26

Alcon price target lowered to $85 from $90 at ArgusAlcon price target lowered to $85 from $90 at Argus

Brett Fishbin

KeyBanc

€75.35

Buy

25.67%

Upside

Reiterated

06/12/26

Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (NYSE: EVMN), Immunome (NASDAQ: IMNM) and Alcon (NYSE: ALC)

Veronika Dubajova

Citi

€95.9→€88.2

Buy

47.09%

Upside

Reiterated

06/11/26

Alcon (ALC) Gets a Buy from Citi

Thomas Stephan

Stifel Nicolaus

€59.94

Hold

-0.03%

Downside

Reiterated

05/21/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alcon (NYSE: ALC) and Oruka Therapeutics (NASDAQ: ORKA)

Jeff Johnson

Robert W. Baird

€83.92→€77.07

Buy

28.53%

Upside

Reiterated

05/07/26

Alcon price target lowered to $90 from $98 at BairdAlcon price target lowered to $90 from $98 at Baird

Matt Miksic

Barclays

€66.79

Hold

11.39%

Upside

Reiterated

05/06/26

Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (NASDAQ: ACAD), Qiagen (NYSE: QGEN) and Alcon (NYSE: ALC)

Jack Reynolds-Clark

RBC Capital

€85.7

Buy

42.93%

Upside

Reiterated

05/06/26

Alcon (ALC) Gets a Buy from RBC Capital

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

ODTXOdyssey Therapeutics, Inc.

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

GPCRStructure Therapeutics, Inc. Sponsored ADR

AMLXAmylyx Pharmaceuticals Inc

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alcon

3 Months

Larry BiegelsenWells Fargo

Success Rate

13/19 ratings generated profit

Average Return

+2.04%

Copying Larry Biegelsen's trades and holding each position for 3 Months would result in 68.42% of your transactions generating a profit, with an average return of +2.04% per trade.

1 Year

Larry BiegelsenWells Fargo

Success Rate

12/19 ratings generated profit

Average Return

+4.57%

Copying Larry Biegelsen's trades and holding each position for 1 Year would result in 63.16% of your transactions generating a profit, with an average return of +4.57% per trade.

2 Years

Anthony PetroneMizuho Securities

Success Rate

13/24 ratings generated profit

Average Return

+4.37%

Copying Anthony Petrone's trades and holding each position for 2 Years would result in 54.17% of your transactions generating a profit, with an average return of +4.37% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2U3 Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 2U3 has received 10 Buy Ratings, 2 Hold Ratings, and 1 Sell Ratings. 2U3 average Analyst price target in the past 3 months is 76.98.

Each month's total comprises the sum of three months' worth of ratings.

2U3 Financial Forecast

2U3 Earnings Forecast

Next quarter’s earnings estimate for 2U3 is €0.76 with a range of €0.72 to €0.80. The previous quarter’s EPS was €0.73. 2U3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 2U3 has Performed in-line its overall industry.

2U3 Sales Forecast

Next quarter’s sales forecast for 2U3 is €2.38B with a range of €2.36B to €2.41B. The previous quarter’s sales results were €2.39B. 2U3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 2U3 has Performed in-line its overall industry.

2U3 Stock Forecast FAQ

What is DE:2U3’s average 12-month price target, according to analysts?

Based on analyst ratings, Alcon’s 12-month average price target is 76.98.

What is DE:2U3’s upside potential, based on the analysts’ average price target?

Alcon has 28.38% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Alcon a Buy, Sell or Hold?

Alcon has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 2 hold ratings and 1 sell ratings.

What is Alcon’s share price target?

The average share price target for Alcon is 76.98. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €91.06 ,and the lowest forecast is €51.42. The average share price target represents 28.38% Increase from the current price of €59.96.

What do analysts say about Alcon?

Alcon’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of Alcon?

To buy shares of DE:2U3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Alcon (2U3) Stock Forecast & Price Target

2U3 Analyst Ratings

2U3 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Alcon

2U3 Analyst Recommendation Trends

2U3 Financial Forecast

2U3 Earnings Forecast

2U3 Sales Forecast

2U3 Stock Forecast FAQ

Detailed List of Analyst Forecasts